This announcement is a separate document:
新天药业：主体及新天转债2022年度跟踪评级报告
Xintian Pharmaceutical: 2022 Annual Tracking Rating Report for Subjects and Xintian Transfer Bonds
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.